Physician profile
Matthew V Benns
NPI 1770621765
$9,693.27
in general payments reported to CMS, 2019-2025
21 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $363 · 2021: $291 · 2022: $262 · 2023: $163 · 2024: $7,547 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,602 · Travel and Lodging: $1,545 · Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,601.77 |
| Travel and Lodging | $1,544.86 |
| Food and Beverage | $1,115.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,711.37 | 2022-2025 | Da Vinci Surgical System |
| Allergan, INC. | $573.14 | 2019-2022 | |
| Avita Medical Americas, LLC | $548.11 | 2019-2025 | Cohealyx, Recell, Permeaderm |
| Acera Surgical, INC. | $144.91 | 2019-2023 | Restrata Wound Matrix |
| Tela Bio, INC. | $123.52 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $90.70 | 2019-2020 | |
| Integra Lifesciences Corporation | $78.38 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Innovation Technologies INC | $56.04 | 2021 | |
| Smith+Nephew, INC. | $52.03 | 2021-2023 | Oasis |
| Csl Behring | $51.78 | 2022-2024 | Kcentra |
| Covidien LP | $49.98 | 2020 | |
| Cerus Corporation | $39.83 | 2023 | Intercept Blood System For Platelets |
| Ethicon US, LLC | $33.85 | 2019 | |
| Boston Scientific Corporation | $33.39 | 2021-2024 | Spyglass Discover |
| Polymedics Innovations INC. | $20.73 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $17.51 | 2024 | |
| Vivus LLC | $17.39 | 2022 | |
| W. L. Gore & Associates, INC. | $13.21 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Solventum Corporation | $13.09 | 2024 | V.A.C.Instill, Prevena |
| Kls-Martin L.P. | $12.48 | 2021 | |
| Medical Device Business Services, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Benns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.